Intranasal Xylitol and Grapefruit Seed Extract Spray to Prevent Recurrent Acute Otitis Media in Children: A Multicenter Controlled Study
Main Article Content
Abstract
Background: Acute otitis media (AOM) is among the most frequent pediatric infections and a principal driver of antibiotic prescribing globally. Rising antimicrobial resistance and the limitations of current preventive strategies have increased interest in non-antibiotic intranasal approaches targeting nasopharyngeal colonization and biofilm formation.
Aims: To evaluate the potential association between intranasal xylitol and grapefruit seed extract (XYL+GSE) administration and recurrent AOM-related outcomes in a pediatric outpatient population.
Methods: A prospective multicenter exploratory controlled clinical study was conducted across 10 outpatient investigational sites in the Prague and Mid-Bohemia region of the Czech Republic. Pediatric outpatients aged 1-15 years with a history of recurrent AOM were prospectively assigned (non-randomized, fixed allocation schedule) to receive either intranasal XYL+GSE or a distilled-water comparator for 3 months. Outcome assessment was performed by study physicians; formal blinding of assessors was not implemented.
Results: A total of 154 participants completed the 3-month treatment period (XYL+GSE: n = 80; control: n = 74). AOM recurrence occurred in 38.8% of participants in the XYL+GSE group compared with 90.5% in the control group (p < 0.001; absolute risk difference 51.8 percentage points, 95% CI 39.2-64.4; NNT = 2; exploratory estimate). Antibiotic use for AOM-related infections was significantly lower in the XYL+GSE group (11.3% vs. 35.1%; p < 0.001), as was overall antibiotic use for any infectious indication (32.5% vs. 52.7%; p = 0.011). Upper respiratory tract infection episodes were lower in the XYL+GSE group, but the difference did not reach statistical significance (p = 0.081). Exploratory microbiological analyses demonstrated an 87.5% reduction in total bacterial isolates in the XYL+GSE group versus 22.0% in controls.
Conclusions: Intranasal XYL+GSE administration was associated with a lower rate of recurrent AOM and reduced antibiotic use in a pediatric outpatient population. These findings support the potential role of microbiome-targeted, non-antibiotic preventive strategies for recurrent upper respiratory infections. Given the non-randomized, exploratory design and absence of formal assessor blinding, results should be interpreted as hypothesis-generating and warrant confirmation in adequately powered, blinded randomized controlled trials.
Keywords: Acute otitis media; xylitol; grapefruit seed extract; antimicrobial resistance; intranasal therapy; biofilm; pediatrics; nasopharyngeal colonization
Aims: To evaluate the potential association between intranasal xylitol and grapefruit seed extract (XYL+GSE) administration and recurrent AOM-related outcomes in a pediatric outpatient population.
Methods: A prospective multicenter exploratory controlled clinical study was conducted across 10 outpatient investigational sites in the Prague and Mid-Bohemia region of the Czech Republic. Pediatric outpatients aged 1-15 years with a history of recurrent AOM were prospectively assigned (non-randomized, fixed allocation schedule) to receive either intranasal XYL+GSE or a distilled-water comparator for 3 months. Outcome assessment was performed by study physicians; formal blinding of assessors was not implemented.
Results: A total of 154 participants completed the 3-month treatment period (XYL+GSE: n = 80; control: n = 74). AOM recurrence occurred in 38.8% of participants in the XYL+GSE group compared with 90.5% in the control group (p < 0.001; absolute risk difference 51.8 percentage points, 95% CI 39.2-64.4; NNT = 2; exploratory estimate). Antibiotic use for AOM-related infections was significantly lower in the XYL+GSE group (11.3% vs. 35.1%; p < 0.001), as was overall antibiotic use for any infectious indication (32.5% vs. 52.7%; p = 0.011). Upper respiratory tract infection episodes were lower in the XYL+GSE group, but the difference did not reach statistical significance (p = 0.081). Exploratory microbiological analyses demonstrated an 87.5% reduction in total bacterial isolates in the XYL+GSE group versus 22.0% in controls.
Conclusions: Intranasal XYL+GSE administration was associated with a lower rate of recurrent AOM and reduced antibiotic use in a pediatric outpatient population. These findings support the potential role of microbiome-targeted, non-antibiotic preventive strategies for recurrent upper respiratory infections. Given the non-randomized, exploratory design and absence of formal assessor blinding, results should be interpreted as hypothesis-generating and warrant confirmation in adequately powered, blinded randomized controlled trials.
Keywords: Acute otitis media; xylitol; grapefruit seed extract; antimicrobial resistance; intranasal therapy; biofilm; pediatrics; nasopharyngeal colonization
Article Details
How to Cite
FERRER, Gustavo et al.
Intranasal Xylitol and Grapefruit Seed Extract Spray to Prevent Recurrent Acute Otitis Media in Children: A Multicenter Controlled Study.
Medical Research Archives, [S.l.], v. 14, n. 7, july 2026.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/7732>. Date accessed: 06 aug. 2026.
doi: https://doi.org/10.18103/mra.2026.0417.
Keywords
Acute otitis media, xylitol, grapefruit seed extract, antimicrobial resistance, intranasal therapy, biofilm; pediatrics, nasopharyngeal colonization
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.